Clinical Quality Measures User Guide (for 2011)
-
Additional Measures (Choose 3 Additional Measures)
- NQF 0001 - (Additional) Asthma Assessment
- NQF 0002 - (Additional) Appropriate Testing for Children with Pharyngitis
- *NQF 0004 (Additional): Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (a) Initiation, (b) Engagement
- NQF 0012 (Additional): Prenatal Care - Screening for Human Immunodeficiency Virus (HIV)
- NQF 0014 (Additional): Prenatal Care - Anti-D Immune Globulin
- NQF 0018 (Additional): Controlling High Blood Pressure
- *NQF 0027 (Additional): Smoking and Tobacco Use Cessation, Medical Assistance
- NQF 0031 (Additional): Breast Cancer Screening
- NQF 0032 (Additional): Cervical Cancer Screening
- (DRAFT) *NQF 0033 (Additional): Chlamydia Screening for Women age 15-24
- NQF 0034 (Additional) Colorectal Cancer Screening
- (DRAFT) *NQF 0036 (Additional): Use of Appropriate Medications for Asthma
- NQF 0043 (Additional) - Pneumonia Vaccination Status for Older Adults
- NQF 0047 - (Additional) Asthma Pharmacologic Therapy
- (DRAFT) NQF 0052 (Additonal) Low Back Pain: Use of Imaging Studies
- NQF 0055 (Additional) Diabetes: Eye Exam
- NQF 0056 (Additional) Diabetes: Foot Exam
- NQF 0059/PQRI 1 (Additional) - Diabetes: Hemoglobin A1c Poor Control
- NQF 0061/PQRI 3 (Additional)- Diabetes: Blood Pressure Management
- (DRAFT) NQF 0062 (Additional): Diabetes Urine Screening
- *NQF 0064 (Additional) - Diabetes: Low Density Lipoprotein (LDL) Management and Control
- NQF 0067 (Additional) Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
- NQF 0068 (Additional) - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
- NQF 0070 (Additional) - Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
- NQF 0073 (Additional): Ischemic Vascular Disease (IVD): Blood Pressure Management
- NQF 0074 (Additional): Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
- NQF 0075 (Additional): Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
- NQF 0081/PQRI 5 (Additional) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- NQF 0083 (Additional) Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- NQF 0084 (Additional): Heart Failure: Warfarin Therapy Patients with Atrial Fibrillation
- NQF 0086 - (Additional) Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
- NQF 0088 - (Additional) Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
- NQF 0089 - (Additional) Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
- (DRAFT) *NQF 0105 - (Additional) Anti-depressant medication management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment
- NQF 0385 (Additional): Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
- NQF 0387 - (Additional) Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen
- NQF 0389 (Additional): Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
- NQF 0575 (Additional): Diabetes: Hemoglobin A1c Control (<8.0%)